Altamira Therapeutics Ltd
CYTO
CYTO was delisted on the 19th of December, 2024.
3 hedge funds and large institutions have $7.74M invested in Altamira Therapeutics Ltd in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 7 closing their positions.
70% less funds holding
Funds holding: 10 → 3 (-7)
79% less capital invested
Capital invested by funds: $37.1M → $7.74M (-$29.3M)
80% less call options, than puts
Call options by funds: $10K | Put options by funds: $50K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 7
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.47M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$4.29M |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$3.56M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.43M |
| 5 |
TAM
Tocqueville Asset Management
New York
|
-$314K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| – | -$33K | – | – |
|
CYTO Hedge Fund Activity: Q3 2016 in Review
3 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q3 2016, worth a combined $7.74M — down 79% from $37.1M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CYTO and 0 opened new positions — a net loss of 7 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Fidelity Investments, exiting entirely with an estimated $6.47M sold.
- 3 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q3 2016, down from 10 in Q2 2016.
- Funds reported $7.74M of Altamira Therapeutics Ltd stock for Q3 2016, down 79% quarter-over-quarter.
- 0 funds opened new Altamira Therapeutics Ltd positions in Q3 2016 and 7 closed out, a net change of -7 holders.
- The largest Altamira Therapeutics Ltd seller in Q3 2016 was Fidelity Investments, an estimated $6.47M sold.
Based on aggregated 13F filings for Q3 2016.